These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 21708485)
21. New anti-tuberculosis agents amongst known drugs. Lougheed KE; Taylor DL; Osborne SA; Bryans JS; Buxton RS Tuberculosis (Edinb); 2009 Sep; 89(5):364-70. PubMed ID: 19699151 [TBL] [Abstract][Full Text] [Related]
22. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain. Raja S; Prakash CR Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582 [TBL] [Abstract][Full Text] [Related]
23. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance. Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862 [TBL] [Abstract][Full Text] [Related]
24. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol. Al-Mutairi NM; Ahmad S; Mokaddas E Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677 [TBL] [Abstract][Full Text] [Related]
25. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors. Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis. Karale UB; Krishna VS; Krishna EV; Choudhari AS; Shukla M; Gaikwad VR; Mahizhaveni B; Chopra S; Misra S; Sarkar D; Sriram D; Dusthackeer VNA; Rode HB Eur J Med Chem; 2019 Sep; 178():315-328. PubMed ID: 31195172 [TBL] [Abstract][Full Text] [Related]
27. Spectinamides: a challenge, a proof, and a suggestion. Viveiros M; Pieroni M Trends Microbiol; 2014 Apr; 22(4):170-1. PubMed ID: 24636244 [TBL] [Abstract][Full Text] [Related]
28. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates. Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500 [TBL] [Abstract][Full Text] [Related]
29. New Griselimycins for Treatment of Tuberculosis. Holzgrabe U Chem Biol; 2015 Aug; 22(8):981-2. PubMed ID: 26295835 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of CoA biosynthesis proteins of Mycobacterium tuberculosis as potential drug targets. Ambady A; Awasthy D; Yadav R; Basuthkar S; Seshadri K; Sharma U Tuberculosis (Edinb); 2012 Nov; 92(6):521-8. PubMed ID: 22954585 [TBL] [Abstract][Full Text] [Related]
32. [Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)]. Tungusova OS; Mar'iandyshev AO Probl Tuberk; 2001; (6):48-9. PubMed ID: 11641963 [No Abstract] [Full Text] [Related]
33. QSAR Studies, Synthesis and Antibacterial Assessment of New Inhibitors Against Multidrug-Resistant Mycobacterium tuberculosis. Kovalishyn V; Brovarets V; Blagodatnyi V; Kopernyk I; Hodyna D; Chumachenko S; Shablykin O; Kozachenko O; Vovk M; Barus M; Bratenko M; Metelytsia L Curr Drug Discov Technol; 2017; 14(1):25-38. PubMed ID: 27829331 [TBL] [Abstract][Full Text] [Related]
34. Designing novel possible kinase inhibitor derivatives as therapeutics against Mycobacterium tuberculosis: An in silico study. Shahbaaz M; Nkaule A; Christoffels A Sci Rep; 2019 Mar; 9(1):4405. PubMed ID: 30867456 [TBL] [Abstract][Full Text] [Related]
35. A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis Patel N; O'Malley T; Zhang YK; Xia Y; Sunde B; Flint L; Korkegian A; Ioerger TR; Sacchettini J; Alley MRK; Parish T Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674058 [TBL] [Abstract][Full Text] [Related]
36. Emerging resistant clone of Mycobacterium tuberculosis in west Asia. Mokrousov I Lancet Infect Dis; 2016 Dec; 16(12):1326-1327. PubMed ID: 27998587 [No Abstract] [Full Text] [Related]
37. Mechanisms of drug resistance in Mycobacterium tuberculosis. Cole ST Immunobiology; 1994 Oct; 191(4-5):584-5. PubMed ID: 7713574 [No Abstract] [Full Text] [Related]
38. Mycobacterium tuberculosis "Beijing" epidemics: a race against mutations? Bhatter P; Chatterjee A; Mistry N Tuberculosis (Edinb); 2012 Jan; 92(1):92-4. PubMed ID: 22015174 [TBL] [Abstract][Full Text] [Related]